GSK whistleblower claims to have been fired after emailing CEO about Nicoderm concerns

Eric Palmer

GlaxoSmithKline's  products are among the leaders in helping smokers kick their habits. But a former employee says the study that showed their edge over competitors was flawed and that he got the boot for pointing it out to his bosses and giving a heads-up by email to CEO Andrew Witty.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS